Clinical Trial Update: Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial investigating neurobiological predictors of response to guanfacine extended release in children and adolescents with ADHD; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Guanfacine Extended Release (guanfacine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-02-14